Description
Levemir (Insulin Detemir)
Levemir (Insulin Detemir) is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus, potency of insulin analogues, including insulin detemir, is expressed in units, whereas the potency of human insulin is expressed in international units. 1 unit insulin detemir corresponds to 1 international unit of human insulin. Levemir can be used alone as the basal insulin or in combination with bolus insulin. It can also be used in combination with oral antidiabetic medicinal products and/or GLP-1 receptor agonists
Our top priority is always the health and safety of the patients that use our products. After careful consideration, we made this decision because of global manufacturing issues, decreasing patient coverage. Do not share your Levemir® FlexPen® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection or get a serious infection from them.
When Levemir is used in combination with oral antidiabetic medicinal products or when added to GLP-1 receptor agonists it is recommended to use Levemir once daily, initially at a dose of 0.1–0.2 units/kg or of 10 units in adult patients. The dose of Levemir should be titrated based on the individual patient’s needs.
We recommend that healthcare providers talk to their patients about alternative treatment options in advance of this discontinuation to ensure continuity of care. When a GLP-1 receptor agonist is added to Levemir, it is recommended to reduce the dose of Levemir by 20%. When Levemir is used as part of a basal-bolus insulin regimen, Levemir should be administered once or twice daily depending on patients’ needs. The dose of Levemir should be adjusted individually. Taking certain diabetes pills called TZDs (thiazolidinediones) with Levemir® may cause heart failure in some people.
